Suntrust Banks’s GSK GSK Stock Holding History

Suntrust Banks’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$18.8M	Sell	351,796 -5,306	-1%	-$273K	0.1%	169
2019 Q2	$17.9M	Sell	357,102 -5,851	-2%	-$294K	0.09%	169
2019 Q1	$19M	Buy	362,953 +40,243	+12%	+$2.01M	0.1%	163
2018 Q4	$15.4M	Sell	322,710 -39,884	-11%	-$1.96M	0.09%	174
2018 Q3	$18.2M	Sell	362,594 -12,888	-3%	-$655K	0.09%	173
2018 Q2	$18.9M	Sell	375,482 -2,608	-0.7%	-$131K	0.1%	163
2018 Q1	$18.5M	Buy	378,090 +88,071	+30%	+$4.1M	0.1%	164
2017 Q4	$12.9M	Sell	290,019 -130,545	-31%	-$6.03M	0.07%	184
2017 Q3	$21.3M	Buy	420,564 +73,900	+21%	+$3.75M	0.13%	138
2017 Q2	$18.7M	Buy	346,664 +53,594	+18%	+$2.86M	0.11%	148
2017 Q1	$15.4M	Buy	293,070 +62,292	+27%	+$3.16M	0.1%	161
2016 Q4	$11.1M	Sell	230,778 -169,708	-42%	-$8.38M	0.07%	198
2016 Q3	$21.6M	Sell	400,486 -44,384	-10%	-$2.43M	0.13%	133
2016 Q2	$24.1M	Buy	444,870 +34,806	+8%	+$1.83M	0.15%	122
2016 Q1	$20.8M	Buy	410,064 +71,095	+21%	+$3.54M	0.13%	128
2015 Q4	$17.1M	Sell	338,969 -59,784	-15%	-$3.05M	0.11%	147
2015 Q3	$19.2M	Sell	398,753 -20,301	-5%	-$1.06M	0.13%	127
2015 Q2	$21.8M	Buy	419,054 +71,463	+21%	+$4.02M	0.14%	123
2015 Q1	$20M	Buy	347,591 +88,520	+34%	+$5.07M	0.13%	133
2014 Q4	$13.8M	Sell	259,071 -25,237	-9%	-$1.41M	0.09%	154
2014 Q3	$16.3M	Sell	284,308 -15,110	-5%	-$926K	0.11%	142
2014 Q2	$20M	Sell	299,418 -3,584	-1%	-$243K	0.14%	128
2014 Q1	$20.2M	Buy	303,002 +5,927	+2%	+$401K	0.07%	285
2013 Q4	$19.8M	Buy	297,075 +28,493	+11%	+$1.85M	0.08%	290
2013 Q3	$16.8M	Buy	268,582 +29,752	+12%	+$1.92M	0.07%	312
2013 Q2	$14.9M	Buy	+238,830	New	+$15.2M	0.07%	305

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Suntrust Banks's GSK Position: Q3 2019 in Review

Suntrust Banks reduced its GSK (GSK) stake by 1.5% in Q3 2019, selling an estimated $273K and leaving 351,796 shares worth $18.8M. The position accounts for 0.1% of the portfolio, ranked #169.

Suntrust Banks first reported a position in GSK in Q2 2013 and has held it in 26 quarters since. The position peaked at $24.1M in Q2 2016. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Suntrust Banks held 351,796 shares of GSK worth $18.8M as of Q3 2019.
Suntrust Banks sold 5,306 GSK shares in Q3 2019, an estimated $273K.
GSK made up 0.1% of Suntrust Banks's portfolio in Q3 2019, its #169 holding.
Suntrust Banks first reported a position in GSK in Q2 2013 and has held it in 26 quarters since.
Suntrust Banks's GSK position peaked at $24.1M in Q2 2016.
806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.